Fair Value Considerations (Tables)

9 Months Ended

Mar. 31, 2023

Fair Value Disclosures [Abstract]

Schedule of fair value on a recurring basis

			Fair Value Measurements at March 31, 2023
	Fair Value at March 31,
	2023		(Level 1)		(Level 2)		(Level 3)
	(In thousands)
Liabilities:
Contingent consideration	$	—	$	—	$	—	$	—
CVR liability		465		—		—		465
Derivative warrant liabilities		1,582		—		—		1,582
Total	$	2,047	$	—	$	—	$	2,047

			Fair Value Measurements at June 30, 2022
	Fair Value at June 30,
	2022		(Level 1)		(Level 2)		(Level 3)
	(In thousands)
Liabilities:
Contingent consideration	$	396	$	—	$	—	$	396
CVR liability		578		—		—		578
Derivative warrant liabilities		1,796		—		—		1,796
Total	$	2,770	$	—	$	—	$	2,770

Schedule of changes in Level 3 inputs

	CVR		Contingent			Derivative		Fixed Payment
	Liability		Consideration			Warrant Liabilities		Arrangement
	(In thousands)
Balance as of June 30, 2022	$	578	$	396	$	1,796	$	13,051
Included in earnings		(113)		(391)		(6,167)		1,202
Purchases, issues, sales and settlements:
Issues		—		—		5,953		—
Settlements		—		(5)		—		(3,575)
Balance as of March 31, 2023	$	465	$	—	$	1,582	$	10,678

Schedule of significant assumptions used in valuation

Significant assumptions used in valuing CVRs were as follows:

	March 31,
	2023
Leveraged Beta	0.82
Market risk premium	6.35	%
Risk-free interest rate	4.79	%
Discount	21.25	%
Company specific discount	10.00	%

Significant assumptions used in valuing derivative warrant liabilities at issuance date were as follows:

	August 9,
	2022
Expected volatility	89.89	%
Equivalent term (years)	4.11
Risk-free rate	3.09	%
Dividend yield	0.00	%

Significant assumptions used in valuing derivative warrant liabilities were as follows:

	March 31,
	2023
Expected volatility	75.51	%
Equivalent term (years)	3.84 - 4.44
Risk-free rate	3.65 - 3.73	%
Dividend yield	0.00	%